Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation.
Brook MO. et al, (2024), Transplantation, 108, 2278 - 2286
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.
Thomas T. et al, (2024), Nat Immunol
Regulatory cell therapy for kidney transplantation and autoimmune kidney diseases.
Ho QY. et al, (2024), Pediatr Nephrol
Multiscale topology classifies cells in subcellular spatial transcriptomics.
Benjamin K. et al, (2024), Nature
Opportunities for High-plex Spatial Transcriptomics in Solid Organ Transplantation.
Cross AR. et al, (2023), Transplantation, 107, 2464 - 2472
Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury.
Cross AR. et al, (2023), JCI Insight, 8
A GMP Protocol for the Manufacture of Tregs for Clinical Application.
O'Neil A. et al, (2023), 2559, 205 - 227
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism.
Cavounidis A. et al, (2022), Mucosal Immunol
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection.
VanDyke D. et al, (2022), Cell Rep, 41
Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis.
Shankar S. et al, (2022), Nat Commun, 13
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.
Shankar S. et al, (2022), J Am Soc Nephrol, 33, 883 - 887
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.
Fletcher CE. et al, (2022), Mol Cancer, 21
Chimeric Antigen Receptors and Regulatory T Cells: The Potential for HLA-Specific Immunosuppression in Transplantation
Wright S. et al, (2022), ENGINEERING, 10, 30 - 43